INS and familial dilated cardiomyopathy: P38 MAPK activity was suppressed in comparison with baseline, while myocardial disruption, cell swelling, and fibrosis were alleviated, indicating the potential of Celastrol to protect against DCM by inhibiting P38 MAPK activation and acting on the insulin resistance pathway.